Literature DB >> 22581637

Distant metastases and survival prediction in head and neck squamous cell carcinoma.

Dong Hwan Lee1, Min Joo Kim, Jong-Lyel Roh, Sung-Bae Kim, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim.   

Abstract

OBJECTIVE: This study was designed to identify the risk factors associated with distant metastases (DM) and survival outcomes in patients with head and neck squamous cell carcinoma (HNSCC). STUDY
DESIGN: Database analysis plus chart review.
SETTING: Tertiary care academic medical center. SUBJECTS AND METHODS: Four hundred four eligible patients were involved who were treated with a minimum 2-year follow-up from January 2005 through August 2009. Confirmation of DM was performed by histopathology or follow-up imaging. Univariate and multivariate analyses were used for factors predictive of DM. The survival of patients was calculated by the Kaplan-Meier method.
RESULTS: Thirty-six of the 404 eligible patients (8.9%) developed DM, most frequently in the lungs (80.6%). Univariate analyses revealed that T and N classifications, lymphovascular invasion and perineural invasion of the primary tumor, and locoregional recurrences were each significantly associated with the development of DM (P < .05). Multivariate analyses showed that T and N classifications and locoregional recurrences were independent predictors of DM (P < .05). The overall 1- and 2-year survival rates of the 36 patients with DMs were 40.6% and 13.5%, respectively. Metastases to more than 1 organ negatively affected patient survival (P < .001).
CONCLUSION: Patients with advanced tumors, nodal involvement, or locoregional recurrences may require more frequent surveillance for the development of DMs.

Entities:  

Mesh:

Year:  2012        PMID: 22581637     DOI: 10.1177/0194599812447048

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.

Authors:  M Allison Wolf; Pier Paolo Claudio
Journal:  Nutr Cancer       Date:  2014-01-21       Impact factor: 2.900

Review 2.  Treatment Strategy for Distant Synchronous Metastatic Head and Neck Squamous Cell Carcinoma.

Authors:  Eliane Tang; Lucien Lahmi; Nicolas Meillan; Gianandrea Pietta; Sébastien Albert; Philippe Maingon
Journal:  Curr Oncol Rep       Date:  2019-11-14       Impact factor: 5.075

3.  ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.

Authors:  Lorenz Kadletz; Gregor Heiduschka; Robert Wiebringhaus; Elisabeth Gurnhofer; Ulana Kotowski; Georg Haymerle; Markus Brunner; Conor Barry; Lukas Kenner
Journal:  Cell Oncol (Dordr)       Date:  2016-12-30       Impact factor: 6.730

4.  A Nomogram for Predicting the Risk of Bone Metastasis in Newly Diagnosed Head and Neck Cancer Patients: A Real-World Data Retrospective Cohort Study From SEER Database.

Authors:  Chao Huang; Jialin He; Zichuan Ding; Hao Li; Zongke Zhou; Xiaojun Shi
Journal:  Front Genet       Date:  2022-05-30       Impact factor: 4.772

Review 5.  Spinal metastasis in head and neck cancer.

Authors:  Gregory M Trilling; Hyongyu Cho; Mohamed A Ugas; Samerah Saeed; Asia Katunda; Waseem Jerjes; Peter Giannoudis
Journal:  Head Neck Oncol       Date:  2012-06-20

6.  Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer.

Authors:  Bin Yan; Robert Vander Broek; Anthony D Saleh; Arpita Mehta; Carter Van Waes; Zhong Chen
Journal:  J Carcinog Mutagen       Date:  2013-08-05

7.  The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis.

Authors:  Changxing Chi; Zhiyi Fan; Binbin Yang; He Sun; Zengpai Zheng
Journal:  J Oncol       Date:  2021-09-27       Impact factor: 4.375

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.